Page last updated: 2024-08-24

aripiprazole and ru 66647

aripiprazole has been researched along with ru 66647 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gagne, JJ; Maclure, M; Schneeweiss, S; Wang, SV	1
Hashiguchi, M; Imai, S; Maruyama, J; Mochizuki, M; Shimizu, M; Uehara, K	1

Other Studies

2 other study(ies) available for aripiprazole and ru 66647

Article	Year
"First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs. American journal of epidemiology, 2014, Sep-15, Volume: 180, Issue:6 Topics: Anti-Bacterial Agents; Antipsychotic Agents; Aripiprazole; Bias; Case-Control Studies; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Databases, Pharmaceutical; Humans; Isoxazoles; Ketolides; Marketing; Medicaid; Pharmacoepidemiology; Piperazines; Product Surveillance, Postmarketing; Quinolones; Sulfonamides; United States	2014
Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions. PloS one, 2015, Volume: 10, Issue:12 Topics: Adverse Drug Reaction Reporting Systems; Aripiprazole; Chemical and Drug Induced Liver Injury; Data Mining; Databases, Factual; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Exenatide; Humans; Hypercalcemia; Ketolides; Pancreatitis; Peptides; Rhabdomyolysis; Rosuvastatin Calcium; Suicide; Teriparatide; Time Factors; United States; United States Food and Drug Administration; Varenicline; Venoms	2015

Article

Year

"First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.

American journal of epidemiology, 2014, Sep-15, Volume: 180, Issue:6

Topics: Anti-Bacterial Agents; Antipsychotic Agents; Aripiprazole; Bias; Case-Control Studies; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Databases, Pharmaceutical; Humans; Isoxazoles; Ketolides; Marketing; Medicaid; Pharmacoepidemiology; Piperazines; Product Surveillance, Postmarketing; Quinolones; Sulfonamides; United States

2014

Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions.

PloS one, 2015, Volume: 10, Issue:12

Topics: Adverse Drug Reaction Reporting Systems; Aripiprazole; Chemical and Drug Induced Liver Injury; Data Mining; Databases, Factual; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Exenatide; Humans; Hypercalcemia; Ketolides; Pancreatitis; Peptides; Rhabdomyolysis; Rosuvastatin Calcium; Suicide; Teriparatide; Time Factors; United States; United States Food and Drug Administration; Varenicline; Venoms

2015